George L Long is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technologies. With a total of 4 patents, his work has had a profound impact on medical science.

Latest Patents

Among his latest patents are innovations related to human protein C. The first patent, titled "Vectors and compounds for expression of human protein C," describes novel DNA compounds that encode human protein C activity. These compounds include a variety of eukaryotic and prokaryotic recombinant DNA expression vectors that drive the expression of protein C activity when transformed into appropriate host cells. This invention allows for the production of various protein C derivatives and precursors, which are essential in treating and preventing vascular disorders. Another patent, "Methods of using recombinant human protein C," further elaborates on the applications of these DNA compounds in medical treatments.

Career Highlights

George L Long is currently employed at Eli Lilly and Company, where he continues to innovate in the field of biotechnology. His work at this prestigious company has allowed him to collaborate with other leading scientists and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Robert F Santerre and Robert J Beckmann. Their collaborative efforts have further advanced the research and development of recombinant DNA technologies.

Conclusion

George L Long's contributions to biotechnology, particularly in the area of human protein C, highlight his role as an influential inventor. His patents not only showcase his innovative spirit but also demonstrate the potential for significant advancements in medical treatments.